244 related articles for article (PubMed ID: 16161993)
1. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
Majoros IJ; Thomas TP; Mehta CB; Baker JR
J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993
[TBL] [Abstract][Full Text] [Related]
2. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis.
Shi X; Majoros IJ; Patri AK; Bi X; Islam MT; Desai A; Ganser TR; Baker JR
Analyst; 2006 Mar; 131(3):374-81. PubMed ID: 16496045
[TBL] [Abstract][Full Text] [Related]
4. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
[TBL] [Abstract][Full Text] [Related]
5. HPLC analysis of PAMAM dendrimer based multifunctional devices.
Islam MT; Majoros IJ; Baker JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):21-6. PubMed ID: 15950555
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
Yue Y; Eun JS; Lee MK; Seo SY
Arch Pharm Res; 2012 Feb; 35(2):343-9. PubMed ID: 22370789
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy.
Wang Y; Guo R; Cao X; Shen M; Shi X
Biomaterials; 2011 Apr; 32(12):3322-9. PubMed ID: 21315444
[TBL] [Abstract][Full Text] [Related]
8. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate.
Bi X; Shi X; Baker JR
J Biomater Sci Polym Ed; 2008; 19(1):131-42. PubMed ID: 18177559
[TBL] [Abstract][Full Text] [Related]
10. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer cells with biotin-dendrimer conjugates.
Yang W; Cheng Y; Xu T; Wang X; Wen LP
Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer-based BH3 conjugate that targets human carcinoma cells.
Myc A; Patri AK; Baker JR
Biomacromolecules; 2007 Oct; 8(10):2986-9. PubMed ID: 17877400
[TBL] [Abstract][Full Text] [Related]
13. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices.
Shi X; Majoros IJ; Baker JR
Mol Pharm; 2005; 2(4):278-94. PubMed ID: 16053331
[TBL] [Abstract][Full Text] [Related]
14. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.
Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
J Biomed Mater Res A; 2007 Jul; 82(1):92-103. PubMed ID: 17269145
[TBL] [Abstract][Full Text] [Related]
15. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
Choi Y; Thomas T; Kotlyar A; Islam MT; Baker JR
Chem Biol; 2005 Jan; 12(1):35-43. PubMed ID: 15664513
[TBL] [Abstract][Full Text] [Related]
17. HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.
Shi X; Bi X; Ganser TR; Hong S; Myc LA; Desai A; Holl MM; Baker JR
Analyst; 2006 Jul; 131(7):842-8. PubMed ID: 16802031
[TBL] [Abstract][Full Text] [Related]
18. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers.
Zhang M; Guo R; Kéri M; Bányai I; Zheng Y; Cao M; Cao X; Shi X
J Phys Chem B; 2014 Feb; 118(6):1696-706. PubMed ID: 24467521
[TBL] [Abstract][Full Text] [Related]
19. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats.
Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
Biomaterials; 2007 Jan; 28(3):504-12. PubMed ID: 16996126
[TBL] [Abstract][Full Text] [Related]
20. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
Hong S; Leroueil PR; Majoros IJ; Orr BG; Baker JR; Banaszak Holl MM
Chem Biol; 2007 Jan; 14(1):107-15. PubMed ID: 17254956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
